Opinion: Hydroxychloroquine And Azithromycin For COVID-19: Benefits TBD, Risks Clear
In the midst of a pandemic, lots of people have ideas for cures. We are desperate for therapies and the virus can be deadly. The problem is that the presumptive cure can add danger to the disease, rather than mitigate it.Source: Forbes
Coronavirus infection may cause lasting damage throughout the body, doctors fear
For a world grappling with the new coronavirus, it’s becoming increasingly clear that even when the pandemic is over, it won’t really be over. Now doctors are beginning to worry that for patients who have survived COVID-19, the same may be true.Source: Los Angeles Times
Hospitals seeing ‘a previously unimaginable shift’ due to COVID-19—are patients afraid to seek medical attention?
As COVID-19 continues to keep healthcare providers busy, fewer patients appear to be seeking care for other serious issues, including cardiovascular complications such as heart attack and stroke.Source: Cardiovascular Business
ERs are seeing up to 60% fewer heart attack patients as those infected with coronavirus fill hospital beds but cardiac emergencies mysteriously 'disappear'
Emergency rooms across the U.S. are seeing less than half of usual number of heart attack patients as beds are filled by those infected with coronavirus.Source: Mary Kekatos
Eric Brandt selected for ACC young investigator award
Eric J. Brandt MD, a postdoctoral fellow at Yale Cardiovascular Medicine, was selected as a finalist for the American College of Cardiology (ACC) Young Investigator Award. He will present his research at the annual Scientific Session March 29.
High-tech Pump May Increase Risk of Death and Bleeding, Study Finds
A new national study finds that the use of the Impella circulatory support device is associated with higher rates of death and major bleeding among patients with acute myocardial infarction and cardiogenic shock who are implanted with mechanical circulatory support devices.
Krumholz Receives the American Heart Association's Clinical Research Prize
Krumholz was recognized “for his work as a founding leader in the field of outcomes research. His work has led to improvements in the quality of care and outcomes for millions of patients nationwide and beyond,” said American Heart Association President Robert A. Harrington, MD, FAHA.
A Better Way to Classify Young Women’s Heart Attacks
A new study, sponsored by Women’s Health Research at Yale, shows how a sex-specific classification system can define and group types of heart attacks that are more common for women. In doing so, the researchers have produced a more accurate guide to treatment and prognosis.
Low mobility predicts hospital readmission in older heart attack patients
Close to 20% of elderly adults who have suffered a heart attack will be readmitted to the hospital within 30 days. Performance on a simple mobility test is the best predictor of whether an elderly heart attack patient will be readmitted, a Yale-led study reports.
Text Messages Show Promise as Next Step for Improving Heart Health in China
Motivational text messages are a well-liked, feasible new way to provide additional support to Chinese patients with heart disease, reports a preliminary study by researchers at Yale and in China. However, the study did not prove that these targeted text messages led to an improvement in blood pressure control amongst the recipients, the intended outcome.
Giant Study Suggests Apple Watch Accurately Catches Atrial Fibrillation
Early results from a giant study of Apple Watch users show the wearable device appears to detect atrial fibrillation (AF) with a high degree of accuracy, and about half the users who got an AF alert said they contacted a doctor.Source: AJMC
Since 1990s, Heart Attacks Have Become Less Deadly and Frequent for Americans
Heart attack prevention and outcomes have dramatically improved for American adults in the past two decades, according to a Yale study in JAMA Network Open. Compared to the mid-1990s, Americans today are less likely to have heart attacks and also less likely to die from them, said the researchers.
Krumholz, Spatz receive funding to develop new 24/7 blood pressure monitor
The National Institute of Biomedical Imaging and Bioengineering has awarded a $1.2 million, four-year grant to investigators at Texas A&M University and Yale University for the development of a wrist-worn, cuffless blood pressure monitoring system.
China’s out of control ‘silent killer’ affects one-third of adults
More than one-third of adults in China have high blood pressure — often dubbed the “silent killer” for its lack of symptoms — but only about one in 20 have the condition under control. These findings are published Oct. 25 in the Lancet’s special issue on China by researchers at Yale and the Chinese National Center for Cardiovascular Disease.
Yale experts selected to conduct medical device surveillance research
Two projects conducted by Yale School of Medicine faculty have been selected as Demonstration Projects by NEST, the National Evaluation System for Health Technology, which was established by the Medical Device Innovation Consortium and funded by FDA.
Heart study finds faulty link between biomarkers and clinical outcomes
Surrogate endpoints (biomarkers), which are routinely used in clinical research to test new drugs, should not be trusted as the ultimate measure to approve new health interventions in cardiovascular medicine, according to a recent study by Yale School of Medicine researchers in JAMA.